The study of familial hypercholesterolemia in Italy: A narrative review.

In this review we outline our experience in the clinical and molecular diagnosis of familial hypercholesterolemia (FH), built up over more than three decades. We started our work by selecting FH patients on the basis of stringent clinical criteria, including extensive family studies. In most patients we confirmed the clinical diagnosis by showing a reduced LDLR activity in skin fibroblasts. After the isolation of LDLR cDNA and the characterization of the corresponding gene by the Dallas group, we started a systematic molecular investigation of our patients first using Southern blotting, and, subsequently Sanger sequencing. Up to now we have been able to identify 260 mutations of LDLR gene in more than 1000 genotyped FH patients, including 68 homozygotes. During this survey we identified 13 mutation clusters located in different geographical districts, which gave us the chance to compare the phenotype of patients carrying the most common mutations. We also found that mutations in APOB and PCSK9 genes were a rare cause of FH in our cohort. Despite our efforts, we failed to identify mutations in candidate genes in ∼20% of cases of definite FH. An exome-wide study, conducted within the context of an international collaboration, excluded the presence of other major genes in our unexplained FH cases. Recently, we have adopted sequencing technology of the next generation (NGS) with the parallel sequencing of a panel of FH targeted genes as a way of obtaining a more comprehensive picture of the gene variants potentially involved in the disease.

[1]  M. Brown,et al.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.

[2]  J. Attwood,et al.  Development of a microsatellite‐based approach to co‐segregation analysis of familial hypercholesterolaemic kindreds , 1997, Annals of human genetics.

[3]  S. Humphries,et al.  Analysis of low density lipoprotein receptor gene mutations and microsatellite haplotypes in Greek FH heterozygous children: six independent ancestors account for 60% of probands , 1998, Human Genetics.

[4]  R. Tiozzo,et al.  Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[5]  R. Fresa,et al.  Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia. , 2006, Atherosclerosis.

[6]  I. Rabbone,et al.  Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[7]  M. Kotze,et al.  A de novo duplication in the low density lipoprotein receptor gene , 1995, Human mutation.

[8]  S. Bertolini,et al.  Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[9]  R. Tiozzo,et al.  A large deletion in the LDL receptor gene--the cause of familial hypercholesterolemia in three Italian families: a study that dates back to the 17th century (FH-Pavia). , 1992, American journal of human genetics.

[10]  S. Bertolini,et al.  A ‘de novo’ point mutation of the low‐density lipoprotein receptor gene in an Italian subject with primary hypercholesterolemia , 1998, Clinical genetics.

[11]  S. Bertolini,et al.  Use of three DNA polymorphisms of the LDL receptor gene in the diagnosis of familial hypercholesterolemia , 1990, Human Genetics.

[12]  J. Weissenbach,et al.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.

[13]  A. Hoes,et al.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention , 2016, Atherosclerosis.

[14]  G. Zuliani,et al.  Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree , 1995, European journal of clinical investigation.

[15]  S. Humphries,et al.  Identification of a common low density lipoprotein receptor mutation (R329X) in the south of England: complete linkage disequilibrium with an allele of microsatellite D19S394. , 1997, Journal of medical genetics.

[16]  K. Hayashi,et al.  A de novo mutation of the LDL receptor gene as the cause of familial hypercholesterolemia identified using whole exome sequencing. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[17]  R. Tiozzo,et al.  Chorionic DNA analysis for the prenatal diagnosis of familial hypercholesterolaemia , 1993, Human Genetics.

[18]  S. Bertolini,et al.  An apparent inconsistency in parent to offspring transmission of point mutations of LDLR gene in familial hypercholesterolemia. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[19]  D. Simons-Morton,et al.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.

[20]  Jonathan C. Cohen,et al.  Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.

[21]  A. Cantafora,et al.  Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. , 2004, Atherosclerosis.

[22]  A. Cantafora,et al.  A "de novo" mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia. , 2002, Biochimica et biophysica acta.

[23]  S. Bertolini,et al.  Analysis of two duplications of the LDL receptor gene affecting intracellular transport, catabolism, and surface binding of the LDL receptor. , 1998, Journal of lipid research.

[24]  G. Watts,et al.  Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[25]  P. Progias,et al.  Familial Hypercholesterolemia in Greek children and their families: genotype-to-phenotype correlations and a reconsideration of LDLR mutation spectrum. , 2014, Atherosclerosis.

[26]  S. Bertolini,et al.  Pvu II polymorphism of low density lipoprotein receptor gene and familial hypercholesterolemia. Study of Italians. , 1988, Arteriosclerosis.

[27]  Jonathan C. Cohen,et al.  Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein , 2001, Science.

[28]  R. Fresa,et al.  Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. , 2013, Atherosclerosis.

[29]  A. Montali,et al.  Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[30]  R. Tiozzo,et al.  Hypercholesterolemia , 2020, Definitions.

[31]  K Kontula,et al.  Familial moderate hypercholesterolemia caused by Asp235-->Glu mutation of the LDL receptor gene and co-occurrence of a de novo deletion of the LDL receptor gene in the same family. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[32]  J. Borén,et al.  Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment , 2015, European heart journal.

[33]  A. Cantafora,et al.  Influence of b-Thalassemia on the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia A Study of Patients With Familial Hypercholesterolemia From Sardinia , 1999 .

[34]  M. Arca,et al.  The history of Autosomal Recessive Hypercholesterolemia (ARH). From clinical observations to gene identification. , 2015, Gene.

[35]  M. Brown,et al.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[36]  S. Humphries,et al.  Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations , 2014, Journal of Medical Genetics.

[37]  John F. Robinson,et al.  Targeted next-generation sequencing in monogenic dyslipidemias , 2015, Current opinion in lipidology.

[38]  R. Tiozzo,et al.  Four novel partial deletions of LDL-receptor gene in Italian patients with familial hypercholesterolemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[39]  V. Meiner,et al.  Prenatal diagnosis of familial hypercholesterolemia caused by the “Lebanese” mutation at the low density lipoprotein receptor locus , 1992, Human Genetics.